342 filings
8-K
ARIA
ARIAD Pharmaceuticals Inc
16 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
6 Feb 17
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
10 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
8 Dec 16
Other Events
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
7 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
eom3qwbhl zcs
30 Nov 16
Other Events
12:00am
8-K
hoj przgz1d6e8
18 Nov 16
ARIAD Announces Data Presentations at the World Conference on Lung Cancer
12:00am
8-K
m9jfrqbtv03a40
7 Nov 16
ARIAD Reports Third Quarter 2016 Financial Results
12:00am
8-K
83zfz
31 Oct 16
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
12:00am
8-K
rattrtv3iagbxzillvh
29 Sep 16
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
12:00am
8-K
17r74
30 Aug 16
ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration
12:00am
8-K
gq8q wfom9mq
28 Jul 16
ARIAD Reports Second Quarter and First Half 2016 Financial Results
12:00am
8-K
o95 a6gj4u3i76aks
22 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
nlo38t6y3pq418e2w736
7 Jun 16
Other Events
12:00am
8-K
4trui3g55njwbwuip
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
zg7ets 6siwfj
26 May 16
Ariad Announces Appointment of Jennifer L. Herron
12:00am
8-K
zzr0k1ym8e
20 May 16
Departure of Directors or Certain Officers
12:00am
8-K
k912ds eht6w9am
19 May 16
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting
12:00am
8-K
drb1glhod855hg0nrnrq
10 May 16
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
12:00am
8-K
cxyak04z1hbfy4g c3
9 May 16
Incyte and Ariad Announce Agreement for Incyte to Acquire
12:00am